A Randomized, Double-blind, Multicenter, Sham-controlled, Safety and Efficacy Study of Conbercept in Patients With mCNV

Clinical trial NCT01809223 · UNKNOWN

Trial details

NCT number: NCT01809223
Sponsor: Chengdu Kanghong Biotech Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Choroid Neovascularization Secondary to Degenerative Myopia

Start date: 2012-08-01
Primary completion: 2014-02-01
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.